News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Clinical - Pre-Clinical
Biocryst Pharmaceuticals (BCRX) Expected To Jump Into Ebola Race In A Few Weeks 8/29/2014
IntelliPharmaCeutics Augments Its Rexista™ Oxycodone Development Program With Novel Overdose Deterrence Technology 8/29/2014
Cannabis Science Inc. Provides Updated Guidance On Its Current Pre-Clinical Drug Development Programs Beginning With The Scientific Cannabis Cultivation Programs In Europe And North America, Testing Multiple Cannabis Strains For Multiple Critical Ailments 8/27/2014
TetraLogic Pharmaceuticals (TLOG) To Present Data From Pre-Clinical Studies With Hepatitis B At The 2014 International Meeting On Molecular Biology Of Hepatitis B Viruses 8/27/2014
REGENX Biosciences, LLC: Attacking A Rare Disease At Its Source With Gene Therapy 8/27/2014
Arch Therapeutics Announces Positive Preclinical Data From Its Study Of AC5 Surgical Hemostatic Device™ In Animals On Blood Thinner 8/25/2014
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Glioblastoma Multiforme 8/25/2014
Ebola-Like Virus Beaten By Tekmira Pharmaceuticals Corporation (TKMR) Drug In Study 8/22/2014
Nuvilex (NVLX) Begins Preclinical Studies With Translational Drug Development To Determine If Nuvilex's Unique Cancer Treatment Can Slow Accumulation Of Malignant Ascites Fluid 8/20/2014
Stemedica International Announces Pre-clinical Data Of Its Alzheimer’s Study 8/20/2014
Novan Therapeutics To Present Antiviral Preclinical Results Of Nitric Oxide-Releasing Drug Candidates For The Treatment Of Papillomavirus 8/14/2014
Nuvilex (NVLX) Provides Update On Status Of Preclinical Studies At Translational Drug Development 8/13/2014
CrystalGenomics Release: Polmacoxib Demonstrates Prevention And Treatment Effects In Colorectal Cancer 8/13/2014
Scancell Release: Synergy Of SCIB1 With Checkpoint Inhibitors 8/12/2014
Cambridge's Sarepta Therapeutics (SRPT) Gets A Lift As Shelved Ebola Drug Offers Hope In Crisis 8/8/2014
PTC Therapeutics, Inc. (PTCT) Release: Orally Delivered Compounds, Which Selectively Modify RNA Splicing Prevent Deficits In Mouse Models Of Spinal Muscular Atrophy 8/7/2014
Idera Pharmaceuticals, Inc. (IDRA) And Collaborators Publish Promising Preclinical Data Targeting Microrna With Gene Silencing Oligonucleotide Technology 8/6/2014
MediciNova, Inc. Announces Positive Results Of MN-001 In Advanced NASH Mouse Model; Medicinova Requests A Meeting With FDA 8/5/2014
Cannabis Science Inc. Initiates Pre-Clinical Studies On Cannabinoid Formulations In Neurological Diseases Including Sleep Disorders With The Highly Reputable Institute For Health And Science On Ageing - INRCA - In Italy 8/4/2014
Syndax Pharmaceuticals Inc. Release: Entinostat Improves Treatment Outcomes When Combined With Immune Checkpoint Blockade In Preclinical Tumor Models 7/30/2014
Advanced Biologics Publishes Additional Osteoamp® Abstracts In The Bone And Joint Journal 7/24/2014
Sirona Biochem Announces Successful Completion of Two First Line Studies By Wanbang Biopharmaceuticals 7/23/2014
Glide Pharma Completes Successful Proof-Of-Concept Study With Novel Solid Dose Formulation Of Octreotide 7/22/2014
La Jolla Pharmaceutical Company (LJPC) Announces Positive Pre-Clinical Data For Oral Galectin-3 Inhibitor In Nonalcoholic Steatohepatitis (NASH) 7/15/2014
Anavex Life Sciences Corp. (AVXL.OB) 3-71 Highly Effective And Disease-Modifying Against All Major Alzheimer's Hallmarks In Preclinical Disease Model 7/14/2014
BrainStorm Cell Therapeutics Inc. Announces Publication Of Preclinical Multidose Study Of NurOwn 7/11/2014
Addex Therapeutics (ADXN.SW) ADX71441 Positive Results In Preclinical Model Of Nicotine Addiction 7/10/2014
Nuvilex (NVLX) Scheduled To Begin Preclinical Studies In Early August 7/9/2014
Domainex Ltd Reports Success Of Its Lead Compound In Pre-Clinical Model Of COPD And Secures £1.4 Million Biomedical Catalyst Award 7/9/2014
TRANSGENE (ENX:TNG) Announces Presentation Of Data On TG1050 Immunotherapy Against Chronic Hepatitis B And Provides Update On Its Joint Venture With Tasly Pharmaceutical In China 7/1/2014
Dicerna Pharmaceuticals (DRNA) Release: Researchers Demonstrate Promise Of Dicerna Investigational Therapy In Preclinical Model Of Primary Hyperoxaluria Type 1 (PH1) 6/30/2014
RedHill Biopharma Ltd. (RDHL) Announces Positive Preliminary Pre-Clinical Data With RHB-104 For The Treatment Of Type 1 Diabetes 6/26/2014
Flamel Technologies (FLML) Announces Positive Preclinical Results For Its Once-a-Week Formulation Of Exenatide 6/25/2014
Galectin Therapeutics Announces That Oral Treatment With Galectin-3 Inhibitor GR-MD-02 Is Efficacious In Preclinical Model Of Fatty Liver Disease With Fibrosis 6/23/2014
Pieris Achieves Milestone Payment In Daiichi Sankyo, Inc. (4568.t) Collaboration To Develop Anticalin® Therapeutics 6/23/2014
Questcor Pharmaceuticals, Inc. (Headquarters) (QCOR) Closes Transaction To Acquire International Rights To Synacthen® And Synacthen® Depot 6/23/2014
Apitope Progresses Graves' Disease Treatment 6/19/2014
Arrowhead Research Corporation (ARWR) Announces New Clinical Candidate ARC-AAT For Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease 6/19/2014
Success In Kadimastem’s First Pre-Clinical Trial For Treatment Of Amyotrophic Lateral Sclerosis (ALS) 6/19/2014
Lixte Biotechnology's Lead Compound Lb-100 Reported To Enhance Chemotherapy Effectiveness In Animal Models Of Liver Cancer 6/18/2014
Aeolus Pharmaceuticals Inc. (AOLS.OB) Announces Publication Of Data Demonstrating Efficacy Of AEOL 10150 In Animal CEES Model Of Mustard Gas Skin Exposure 6/18/2014
Novogen Limited (NVGN) Touts Successful Proof-Of-Concept Studies For Trx-1 6/17/2014
Zealand Pharma  (ZEAL.CO) Presented New Data On Two Novel Peptide Therapeutics From Its Preclinical Diabetes Pipeline At The American Diabetes Association 74th Scientific Sessions 6/17/2014
D-Pharm Ltd.'s DP-b99 Prevents Abnormal Neuronal Plasticity And Pathological Brain Reorganization 6/12/2014
MediciNova, Inc. Announces Positive Results In Study Of MN-001 In Mouse Model Of Pulmonary Fibrosis 6/12/2014
Positive Preclinical Performance Of greenovation Biotech GmbH`s Lead Candidate moss-?Gal 6/12/2014
Five Scientific Communications At The European Academy Of Allergy And Clinical Immunology Congress Further Support DBV Technologies's EPIT™ Disease Modifying Effect 6/11/2014
Epizyme (EPZM) To Give Oral Presentation On Pre-Clinical Models And Early Clinical Observations Of EZH2 Inhibitor EPZ-6438 At American Society of Hematology Meeting On Lymphoma Biology August 10-13, 2014 6/10/2014
BrainStorm Cell Therapeutics Inc. Expands Pipeline With Initiation Of Pre-Clinical Study In Autism 6/10/2014
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data With Development Candidate For ALN-CC5, A Subcutaneously Administered RNAi Therapeutic Targeting Complement Component C5 In Development For The Treatment Of Complement-Mediated Diseases 6/9/2014
TetraLogic Pharmaceuticals (TLOG) Announces Preclinical Data Indicating Birinapant's Breadth Of Activity In Models Of Infectious Disease 6/9/2014
Cellectis And Accelera (Nerviano Medical Sciences (NervianoMS)) Sign An Agreement To Complete Preclinical Studies Of Cellectis’ Lead Product Candidate UCART19 6/5/2014
Data Published By Researchers At The National Cancer Institute Further Identifies How Advaxis, Inc.'s Lm-LLO Immunotherapy Eradicates Tumors 6/4/2014
Galmed Pharmaceuticals Release: Recently Published Independent Research Supports The Importance Of Reverse Cholesterol Transport On NASH Pathogenesis 6/4/2014
Thrasos Therapeutics Presents Preclinical Data Demonstrating THR-184 Prevents Loss Of Kidney Function Following Acute Ischemic Injury 6/3/2014
Implandata Successfully Launched Pre-Clinical Studies For New To The World Implantable 24h Extraocular Sensor For Intraocular Pressure Measurement At Glaucoma Patients 6/3/2014
Immunomedics, Inc. (IMMU) Reports Development Of Improved Cancer Immunotherapy At The 2014 Annual Meeting Of The American Society of Clinical Oncology 6/2/2014
Theralase Technologies Inc. (TLT.V) Discovers Anti-Cancer Memory Response 6/2/2014
Inotek Pharmaceuticals Corporation Announces Study Results Demonstrating Neuroprotective Properties Of Trabodenoson, Its Lead Drug Candidate For Glaucoma 5/30/2014
Sangamo BioSciences, Inc. (SGMO) Announces Publication Of Preclinical Data Demonstrating Gene Correction In SCID-X1 Human Hematopoietic Stem Cells 5/29/2014
Neurotrope Announces Publication Of Positive Human Cell Culture And Mouse Model Data Of Bryostatin 1 5/28/2014
Neogen Corporation (NEOG) Disinfectants Proven Effective Against Deadly Pig Virus 5/28/2014
Novogen Limited (NVGN) Identifies Highly Active Drug Candidates Against Prostate Cancer 5/27/2014
Bionure Inc.’s MS Drug Candidate Shows Positive Results For Myelin Repair In Cell Culture Assay 5/27/2014
Global Genomics Group Announces Completion Of Enrollment In GLOBAL Study With 7,500 Patients 5/27/2014
Alnylam Pharmaceuticals (ALNY) And Collaborators Publish Pre-Clinical Results With ALN-AS1, An RNAi Therapeutic Targeting Aminolevulinic Acid Synthase-1 (ALAS-1) For The Treatment Of Hepatic Porphyrias, In The Proceedings Of The National Academy Of Sciences 5/21/2014
Stemline Therapeutics, Inc. (STML) Announces Presentation Of SL-401 Preclinical Efficacy Data In Multiple Myeloma At The 2014 American Society of Clinical Oncology Annual Meeting 5/19/2014
Batu Biologics Authors Peer-Reviewed Publication On Intravenous Vitamin C As Adjuvant To Cancer Immunotherapy 5/16/2014
TRANSGENE (ENX:TNG) Reports Progress With Its Proprietary Oncolytic Immunotherapy To Treat Solid Tumors 5/15/2014
Cynapsus Therapeutics Announces No Buccal Mucosal Irritation In FDA Registration Study Of APL-130277 For Parkinson’s Disease 5/14/2014
ChromaDex, Inc. Initiates Second Human Clinical Study For Its Caffeine Ingredient, PURENERGY® 5/14/2014
RxGen, Inc. And ProLynx Present Data On Ocular Delivery Platform 5/13/2014
Aratana Therapeutics (PETX) Initiates Pivotal Study For AT-001 5/12/2014
Alnylam Pharmaceuticals (ALNY) Announces New RNAi Therapeutic Program For The Treatment Of Hepatitis B Virus (HBV) Infection And Reports An Up To 2.3 Log10 Reduction Of HBV Surface Antigen (HBsAg) In Chronically Infected Chimpanzees 5/12/2014
Da Volterra Presents New Data Supporting DAV132 As A Promising Candidate To Protect The Intestinal Flora And Prevent Severe Clostridium Difficile Infections 5/12/2014
Apitope Initiates Preclinical Development Of Peptide Therapy, ATX-F8-117, To Treat Factor VIII Intolerance 5/7/2014
MacroGenics, Inc. (MGNX) Presents Pre-Clinical Data On Inhibition Of Autoimmune Diseases With DART Candidate MGD010 At IMMUNOLOGY 2014 5/6/2014
Cempra Pharmaceuticals, Inc. Presents Late-Breaker On Solithromycin's Anti NASH Effects In An Animal Model At DDW 2014 5/6/2014
Alnylam Pharmaceuticals (ALNY) Advances Development Candidate For ALN-AAT, A Subcutaneously Administered RNAi Therapeutic Targeting Alpha-1 Antitrypsin (AAT) In Development For The Treatment Of AAT Deficiency-Associated Liver Disease 5/6/2014
Hemispherx Biopharma (HEB) Release: Alferon® N Effective Against MERS (Middle East Respiratory Syndrome) Virus In-Vitro 5/5/2014
RXi Pharmaceuticals (RXII) Announces Positive Results With RXI?109 In The Eyes Of Cynomolgus Monkeys As Part Of A Dose Range Finding Study 5/2/2014
Catabasis Pharmaceuticals, Inc. Describes Modulation Of SREBP As Mechanism For CAT-2003 5/1/2014
Complexa, Inc. Initiates First Clinical Trial Of CXA-10 for Acute Kidney Injury 5/1/2014
Liquidia Technologies Inc. To Present New Data On Next-Generation Multivalent Pneumococcal Vaccine 5/1/2014
Problem For Science? Lab Mice Get Stressed Out Around Men, But Not Women, McGill University Study 5/1/2014
Anavex Life Sciences Corp. (AVXL.OB) Encouraged By Scientific Data Confirming Sigma-1 Receptor Agonist Is Potentially Disease-Modifying In Parkinson's Disease 4/29/2014
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data On Rnai Therapeutics Targeting Transthyretin (TTR) For The Treatment Of TTR-Mediated Amyloidosis (ATTR) 4/29/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: Preclinical Data For Lubiprostone And Unoprostone Isopropyl To Be Presented At Experimental Biology Conference 2014 4/28/2014
Synthetic Biologics, Inc. (SYN)' Reports Preclinical Data To Support Clinical Development Of Novel Pertussis Therapeutic 4/23/2014
Bacterin International, Inc. Announces Preclinical Results On The Use Of Osteoselect® DBM Putty Published In The Journal Of Craniofacial Surgery 4/23/2014
Rexahn Pharmaceuticals, Inc. (RNN) Presents Data From Preclinical Studies Of RX-21101 4/21/2014
Harvard Apparatus (HART) Regenerative Technology Collaborator Successfully Transplants Regenerated Esophagus Into Rat 4/15/2014
True North Therapeutics Publishes Study In Blood Demonstrating Ex Vivo Efficacy Of A C1s Antibody In Cold Agglutinin Disease Patient Samples 4/14/2014
Intercept Pharmaceuticals (ICPT) Announces Preclinical Data Demonstrating OCA's Potential Role In Preventing Complications Of Cirrhosis 4/11/2014
Albireo’s Lead Compound In Cholestatic Liver Diseases, A4250, Protects Against Bile Acid-Mediated Cholestatic Liver Injury In Mice 4/11/2014
ERYtech Pharma Picks Up A New Candidate For Its Tumor Starvation Pipeline 4/9/2014
Immunomedics, Inc. (IMMU) Reports Preclinical Results On SN-38 Antibody-Drug Conjugates As A Potential Novel Platform For Treating Cancer 4/8/2014
Hemispherx Biopharma (HEB) Announces New Publication Enlarges The Understanding Of Ampligen® Safety Profile Across Diverse Animal Species And Focuses On The Unique TLR-3 Receptor/Ampligen(R) Interaction 4/8/2014
Kadmon Corporation Presents Preclinical Results Demonstrating KD019 Activity In Trastuzumab Resistant HER2+ Breast Cancer 4/8/2014
MacroGenics, Inc. (MGNX) Presents Pre-Clinical Data Demonstrating Potent Activity With Colorectal Cancer Product Candidate MGD007 At The American Association for Cancer Research Annual Meeting 4/7/2014
Domainex Ltd Programme Shows Great Promise For The Treatment Of Inflammatory Diseases, Such As Chronic Obstructive Pulmonary Disease (COPD) 4/7/2014
Threshold Pharmaceuticals, Inc. (THLD) Announces Results Of Two New Preclinical Studies Evaluating Novel Combinations Of TH-302 With Immunotherapy, Antiangiogenic Therapy, And Radiotherapy To Be Presented At American Association for Cancer Research Annual Meeting 2014 4/4/2014
Cempra Pharmaceuticals, Inc.'s Solithromycin Demonstrates Therapeutic Potential Beyond Anti-Bacterial Activity 4/4/2014
Antisense Therapeutics Limited (ANP.AX) Release: ATL1102 For MS - Toxicology Study Main Findings 4/1/2014
Nuvilex Selects Translational Drug Development (TD2) To Advance Treatment For Pancreatic Cancer 4/1/2014
TetraLogic Pharmaceuticals (TLOG) Announces Publication Of Preclinical Characterization Of Birinapant 4/1/2014
Egalet Reports Positive Outcome Of First Phase Of Category 1 Abuse Deterrence Studies For Egalet-001 3/31/2014
Kindred Bio (KIN) Announces Initiation Of Pivotal Clinical Study For SentiKin™ In Dogs 3/31/2014
Pulmokine Awarded $1.5 Million Stage B VITA Contract To Advance Inhaled Kinase Inhibitors For Pulmonary Arterial Hypertension 3/27/2014
Cempra To Present Late-Breaker On Solithromycin Reducing Inflammation In An Animal Model For Cancer Chemotherapy-Induced Lung Injury 3/27/2014
AHCC Research Association Release: HPV Eradicated By AHCC Supplement, Preclinical Study Suggests 3/24/2014
Patrys Limited (PAB.AX) PAT-LM1 Advancing To The Clinic 3/24/2014
Isis Pharmaceuticals, Inc. (ISIS) Announces Antisense Targeting Of HBV Produces Dose-Dependent Reductions In Hepatitis B Virus In An Animal Model Of HBV 3/24/2014
GeoVax Labs Inc. (GOVX.OB) Announces Publication Of Repeat Challenge Preclinical Trial In The Journal Of Virology 3/19/2014
Calithera Biosciences, Inc. Presents Preclinical Data For CB-839 Activity And Glutaminase Inhibition In Solid And Hematologic Tumors 3/18/2014
Novagen, Inc. And CanTx Experimental Drug, Trx-1, Proves Effective In Vivo 3/18/2014
Kymab Announces Publication Of The Kymouse Technology In Nature Biotechnology 3/17/2014
The CMTA Announces Expansion of Preclinical Testing For Hereditary Neuropathy Therapies 3/14/2014
Preclinical Data Presentations At Keystone Symposia Highlight Broad Immunotherapy Potential Of Peregrine Pharmaceuticals, Inc. (PPHM)' PS-Targeting Antibodies 3/14/2014
Preclinical Results For Pluristem Therapeutics (PSTI)'s PLX-PAD Cells In Tendon Injury Presented At American Academy of Orthopaedic Surgeons' Annual Meeting 3/12/2014
Anavex Life Sciences Corp. (AVXL.OB) Encouraged By Scientific Data Confirming Sigma-1 Receptor Agonist Extends Survival in ALS (Lou Gehrig's Disease) 3/10/2014
Heat Biologics Presents Preclinical Data From Comparative Combination Cancer Immunotherapy Research Study At Keystone Symposia On Immune Evolution In Cancer 3/10/2014
Research Report Confirms Opportunity For Anavex Life Sciences Corp. (AVXL.OB) Anti-Cancer And Neuropathic Pain Compounds 2/26/2014
Kindred Bio (KIN) Announces Initiation Of Pivotal Clinical Study For Atokin™ In Dogs 2/20/2014
Preclinical Study Results Of Merrimack Pharmaceuticals Inc. (MACK)'s MM-141 Published In Molecular Cancer Therapeutics 2/18/2014
Mirna Therapeutics, Inc. Announces Scientific Publication That Suggests Enhanced Potency Of Lead Therapeutic Microrna In Combination With FDA Approved Lung Cancer Dru 2/18/2014
New Drug Candidate From Vivolux Starves Cancer Cells – Clinical Study Due To Begin Shortly 2/18/2014
BioLineRx Ltd. Announces Positive Preclinical Results For Novel Treatment For Chronic Myeloid Leukemia 2/12/2014
DATATRAK International, Inc. (DATA) Enters Preclinical Trials Extending Leadership Across All Trial Phases 2/4/2014
Cellectis Grants genOway An Exclusive Sublicense For Its Homologous Recombination Technology In The Field Of Genetically Modified Rodent Models 2/4/2014
GENFIT Corp. (ALGFT): Preclinical Data Support Anti-Cancer Effects Of GFT505 1/29/2014
Alcobra (ADHD) Announces New Biomarker Finding In A Follow-Up Fragile X Animal Study For MG01CI 1/27/2014
Novozymes Biopharma Announces New Data Highlighting Potential For Monthly Drug Dosing 1/27/2014
NovoCure Ltd. Enrolls First Patient In Pilot Clinical Trial Of Novottf™ Therapy Plus Gemcitabine For First-Line Treatment Of Advanced Pancreatic Adenocarcinoma 1/24/2014
Clasado And University of Oxford Demonstrate Effect Of Prebiotics On Brain And Gut In Pre-Clinical Study 1/23/2014
Karyopharm Therapeutics (KPTI) Presents Clinical Data On Selinexor (KPT-330) In Colorectal Cancer From Ongoing Phase 1 Study And Preclinical Data On Novel PAK4 Inhibitors At American Society of Clinical Oncology 2014 Gastrointestinal Cancers Symposium 1/22/2014
Preclinical Study Demonstrates Effect Of Galectin Therapeutics Inhibitor On Serum Biomarker In Fatty Liver Disease With Fibrosis 1/21/2014
Innovimmune Biotherapeutics, Inc.'s Preclinical Data On Highly Selective ROR Gamma Inhibitor Prevents Multiple Sclerosis In Mice 1/15/2014
MediciNova, Inc. Announces Positive Results In NASH Mouse Model With MN-001 And Prepares To Initiate Phase 2 Trial In The U.S. 1/14/2014
Merrimack Pharmaceuticals Inc. (MACK) To Present Preclinical Data At The American Society of Clinical Oncology 2014 Gastrointestinal Cancers Symposium 1/13/2014
Cubist Pharmaceuticals, Inc. (CBST) Submits Clinical Trial Application To Initiate First-In-Human Study Of CB-618—A Beta-Lactamase Inhibitor Discovered To Combat Antibiotic Resistance 1/10/2014
NovoCure Ltd. Release: Data Published In Pancreatology Demonstrates Activity Of NovoTTF™ Therapy In Preclinical Models Of Pancreatic Cancer, Alone And In Combination With Chemotherapy 1/7/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Reports Successful Completion Of Type B Breakthrough Therapy Meeting With FDA On Firdapse Tablets Development Program 1/6/2014
New Research Published In Journal Of Biotechnology Highlights Utility Of InVitria’s Recombinant Human Leukemia Inhibitory Factor In Stem Cell Culture 1/6/2014
Immune Response BioPharma To Develop Annual HIV Vaccine RemuneVax Based On Current HIV Strain 12/23/2013
Galectin Therapeutics Release: Published Preclinical Study Demonstrates Therapeutic Effect Of Galectin Inhibitors In Fatty Liver Disease With Fibrosis 12/19/2013
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data On Pharmacology Of Galnac-Sirna Conjugates 12/19/2013
Biocryst Pharmaceuticals (BCRX) Advances Second Generation Oral Plasma Kallikrein Inhibitors For Hereditary Angioedema Into Preclinical Development 12/18/2013
Preclinical Data Support Endocyte, Inc. (ECYT)'s Folate Receptor-Targeted Small Molecule Drug Conjugates For Treatment Of Triple Negative Breast Cancer 12/17/2013
Galapagos NV (GLPG.BR) Selects Pre-Clinical Candidate For Cystic Fibrosis 12/16/2013
Evotec AG (EVTG.F): Results Of Pre-Clinical Studies Lead To Reduction In Revenues, Nevertheless Profitable And More Than EURO 90 M Cash For 2013 Confirmed 12/13/2013
Evotec AG (EVTG.F) Receives Pre-Clinical Milestone As Part Of Its Discovery Alliance With Boehringer Ingelheim Corporation 12/10/2013
MacroGenics, Inc. (MGNX) Announces Presentation Of Pre-Clinical Data On DART® Molecule Targeting CD123-Positive Leukemic Stem Cells At 55th Annual Meeting Of The American Society of Hematology 12/10/2013
Selecta Biosciences, Inc. Announces Successful Pre-Clinical Study Of SEL-201 As An Antigen-Specific Immune Tolerance Treatment For Patients Receiving Factor VIII Therapy 12/9/2013
True North Therapeutics Presents Preclinical Results Showing Potential Of TNT009 To Treat Complement-Mediated Rare Diseases 12/9/2013
Nimbus Discovery IRAK4 Inhibitor Demonstrates Synergistic Effects In Preclinical Studies With Three Kinase Inhibitors For The Treatment Of Lymphoid Malignancies 12/9/2013
Synta Pharmaceuticals (SNTA) Announces Publications Demonstrating Ganetespib Activity In Triple-Negative Breast Cancer Models 11/22/2013
Aratana Therapeutics Announces Positive Top-Line Results From AT-001 Dose-Ranging Field Study In Client-Owned Dogs With Osteoarthritis 11/21/2013
Animal Study Published In Muscles, Ligaments And Tendons Journal Demonstrates Use Of Rotation Medical Collagen Scaffold To Induce Formation Of New Tendon-Like Tissue 11/20/2013
Inovio Pharmaceuticals (INO)'s DNA Vaccine For The Deadly MERS Virus Induces Robust Immune Response In Preclinical Trial 11/20/2013
Capstone Therapeutics (CAPS) Announces A Lipimetix Development, LLC Presentation At The American Heart Association Scientific Sessions: Pre-Clinical Data Demonstrating Significant Post Treatment Benefit Of AEM-28 On Established Atherosclerotic Lesions 11/19/2013
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Publication Of Preclinical Proof-Of-Principle Of CPP-115 Efficacy in Suppressing Infantile Spasms In Epilepsia 11/18/2013
Cempra Pharmaceuticals, Inc. Release: Preclinical Study Suggests That Solithromycin May Provide An Effective Antimicrobial Approach For Prevention And Treatment oOf Intrauterine Infections In Pregnancy 11/18/2013
OXiGENE (OXGN) Announces Preclinical Data Presentation On Novel Anticancer Compounds, Benzosuberenes, Demonstrating Potent Anti-Proliferative Activity 11/18/2013
Enzo Biochem (ENZ) Announces Study In Leading Scientific Journal Linking Idiopathic Pulmonary Fibrosis, A Deadly Human Disease With No Effective Treatment Options, To Presence Of A Monkey Virus 11/15/2013
Aduro Biotech Presents Preclinical Data On Enhanced Anti-Tumor Activity With Small-Molecule Immunotherapy Program 11/14/2013
iPierian Inc. Announces Oral Presentation Of Tau Antibody Preclinical Efficacy Study Which Showed Significant Reduction In Alzheimer’s Disease Progression 11/13/2013
Tekmira Pharmaceuticals Corporation Announces New Preclinical Data From Anti-Viral Programs 11/13/2013
Anavex Life Sciences Corp. (AVXL.OB) Announces Positive Data For ANAVEX 2-73 In Alzheimer's Disease 11/12/2013
Antegrin Announces Publication In Nature Medicine Of Preclinical Data In Fibrosis Models 11/12/2013
Neuroptis Biotech Announces The Preclinical Results For Its Dry Eye Product ML7 11/12/2013
AM-Pharma Holding BV Presents Positive Data From recAP Preclinical Study at American Society of Nephrology Meeting 11/8/2013
Regulus Therapeutics, Inc. Presents Positive Preclinical Data Demonstrating That microRNA-21 Plays an Important Role in Alport Syndrome 11/8/2013
"New" Infectious Diseases: Clinical Tests on Innovative Themis Vaccine 11/7/2013
HemoShear, LLC to Develop Human Cancer Models to Improve Industry Success Rates in New Anticancer Drug Development 11/7/2013
Emergent BioSolutions (EBS) Presents Preclinical Data on ES414, Its Lead Bispecific ADAPTIR Therapeutic for Prostate Cancer 11/6/2013
VG Life Sciences, Inc. (VGLS) Announces the Initiation of IND-Enabling Animal Safety Studies 11/4/2013
Achillion Pharmaceuticals, Inc. (ACHN)'s Uridine-Analog Nucleotide Prodrug, ACH-3422, Shows Compelling Preclinical Profile 11/4/2013
Safety of Pluristem Therapeutics (PSTI)'s PLX Cells Demonstrated in Pre-Clinical Pregnancy Model 11/4/2013
Regulus Therapeutics, Inc. Release: Positive Preclinical Profile of RG-101, a GalNAc-conjugated anti-miR Targeting microRNA-122, Supports Clinical Development for the Treatment of HCV 11/4/2013
AlphaMed Release: MAPCs Bring Lasting Improvements After Brain Injury, Pre-Clinical Study Finds 11/4/2013
AIMM Therapeutics' Pre-Fusion RSV Antibodies Facilitate Improved Approach to Vaccine Development 11/4/2013
SAGE Therapeutics’s Discovery of Novel Allosteric Therapeutic Approach for a Broad Range of CNS Disorders Published in Journal of Neuroscience 10/30/2013
Aeolus Pharmaceuticals Inc. (AOLS.OB)' AEOl 10150 Significantly Improves Survival and Protects Lungs in Mice Exposed to Lethal Radiation 10/29/2013
Neovasc Inc. (NVC) Announces Publication of Positive Tiara™ Preclinical Data in the Journal JACC: Cardiovascular Interventions 10/29/2013
Ablynx (ABLYF) to Present Pre-clinical Proof-of-Concept Data on ALX-0761 at American College of Rheumatology 10/28/2013
Karyopharm Therapeutics Announces Oral Presentations at the American College of Rheumatology on the Use of Selective Inhibitors of Nuclear Export (SINE) XPO1 Antagonists in Preclinical Models of Autoimmune Disease 10/23/2013
ZIOPHARM Oncology, Inc. (ZIOP.OB) and Intrexon Corporation Announce Presentation of Data Highlighting Versatility of Novel Gene Expression and Control Technology 10/22/2013
Stellar Biotechnologies, Inc. Immunotherapy Technology Demonstrates Protection Against Clostridium Difficile Infection in Preclinical Study 10/21/2013
NanoViricides, Inc. (NNVC.PK) Says Early Results Indicate that FluCide® Was Extremely Safe in a Non-GLP Small Animal Tox Study 10/21/2013
Celmatix, Inc. Study Shows Women May be Stopping IVF Treatment Prematurely 10/17/2013
Preclinical Results Show Alliqua, Inc. (Formerly known as HepaLife Technologies Inc.) (ALQA)'s Investigational Lidocaine Transdermal Patch Compares Favorably to Lidoderm Patch 10/16/2013
OXiGENE (OXGN) to Present Preclinical Data Demonstrating Antitumor Activity of ZYBRESTAT® in Pancreatic Neuroendocrine Tumor Model 10/16/2013
Compugen Ltd. (CGEN) Presents Experimental Results Supporting Induction of Immune Tolerance by CGEN-15001 Drug Candidate 10/16/2013
S-TARget Achieves Clinical Proof of Concept for Allergy Vaccine SG100 in Asthmatic Non-Human Primates 10/10/2013
Medivir AB (MVIRb.F) Release: MIV-247 Has Been Selected as a Candidate Drug and Enters Development for the Treatment of Neuropathic Pain 10/10/2013
Galectin Therapeutics' Preclinical Data Published in PLOS ONE Show Its Galectin Inhibitors Reverse Cirrhosis and Significantly Reduce Fibrosis and Portal Hypertension 10/10/2013
Medivir AB (MVIRb.F): MIV-247 Has Been Selected as a Candidate Drug and Enters Development for the Treatment of Neuropathic Pain 10/10/2013
Dicerna Pharmaceuticals Announces Publication of Data Demonstrating Tumor Growth Inhibition From Knockdown of Key Oncogene Using Dicer Substrate RNAi Compounds 10/9/2013
Compugen Ltd. (CGEN) Drug Candidate Demonstrates High Effectiveness in Type I Diabetes Animal Model 10/9/2013



//-->